Percheron Therapeutics LimitedASX: PER

Phase II clinical trial in DMD Fully Enrolled

May 24, 2019 at 3:28 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment